Business Description
BioLargo Inc
NAICS : 325180
SIC : 2819
ISIN : US09065A1007
Total Employee Number:
46Compare
Compare
Traded in other countries / regions
BLGO.USA IPO Date
1991-12-19Description
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, water and wastewater treatment, industrial odor, VOC control, air quality control, and infection control. The company has six segments: ONM Environmental; Clyra Medical; BLEST; BETI; BEST; and BioLargo Canada. ONM Environmental, which sells odor and volatile organic control products and services, located in Westminster, California, derives the maximum revenue.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 3.17 | |||||
Debt-to-EBITDA | -0.36 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -29.68 | |||||
Beneish M-Score | -4.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.4 | |||||
3-Year EBITDA Growth Rate | -34.3 | |||||
3-Year EPS without NRI Growth Rate | -10.5 | |||||
3-Year FCF Growth Rate | -34.9 | |||||
3-Year Book Growth Rate | -10.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.53 | |||||
9-Day RSI | 49.58 | |||||
14-Day RSI | 47.74 | |||||
3-1 Month Momentum % | -19.86 | |||||
6-1 Month Momentum % | -38.24 | |||||
12-1 Month Momentum % | -39.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.1 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.84 | |||||
Days Inventory | 41.19 | |||||
Days Sales Outstanding | 104.7 | |||||
Days Payable | 159.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.5 | |||||
Shareholder Yield % | -14.79 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.39 | |||||
Operating Margin % | -219.12 | |||||
Net Margin % | -230.04 | |||||
EBITDA Margin % | -278.71 | |||||
FCF Margin % | -167.78 | |||||
OCF Margin % | -167.21 | |||||
ROE % | -224.35 | |||||
ROA % | -131.69 | |||||
ROIC % | -221.26 | |||||
3-Year ROIIC % | -175.7 | |||||
ROC (Joel Greenblatt) % | -459.81 | |||||
ROCE % | -285.82 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.94 | |||||
PB Ratio | 10.7 | |||||
Price-to-Tangible-Book | 10.7 | |||||
EV-to-EBIT | -2.11 | |||||
EV-to-EBITDA | -2.17 | |||||
EV-to-Revenue | 6.04 | |||||
EV-to-FCF | -3.6 | |||||
Price-to-GF-Value | 1.19 | |||||
Price-to-Median-PS-Value | 0.38 | |||||
Earnings Yield (Greenblatt) % | -47.39 | |||||
FCF Yield % | -27.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BLGO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioLargo Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.612 | ||
| EPS (TTM) ($) | -0.044 | ||
| Beta | 0.4135 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 44.26 | ||
| 14-Day RSI | 47.74 | ||
| 14-Day ATR ($) | 0.012423 | ||
| 20-Day SMA ($) | 0.112362 | ||
| 12-1 Month Momentum % | -39.7 | ||
| 52-Week Range ($) | 0.095 - 0.2337 | ||
| Shares Outstanding (Mil) | 320.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioLargo Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioLargo Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 120 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 119 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 11:00 | In 29 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 28 days | ||
| General meeting for 2026 | 2026-07-17 10:00 | In 1 day | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.13 (+1.90%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-05 12:00 | 0.18 (-0.74%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-05 | 0.18 (-0.74%) | ||
| Annual report for 2025 | 2026-03-04 | 0.18 (-1.97%) | ||
| Sidoti\'s Micro-Cap Virtual Conference | 2026-01-22 13:00 | 0.18 (-1.51%) |
Show
Entries
BioLargo Inc Frequently Asked Questions
What is BioLargo Inc(BLGO)'s stock price today?
The current price of BLGO is $0.11. The 52 week high of BLGO is $0.23 and 52 week low is $0.10.
When is next earnings date of BioLargo Inc(BLGO)?
The next earnings date of BioLargo Inc(BLGO) is 2026-08-14 Est..
Does BioLargo Inc(BLGO) pay dividends? If so, how much?
BioLargo Inc(BLGO) does not pay dividend.
Guru Commentaries on OTCPK:BLGO
No articles.
Press Release
Articles on BioLargo Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers